Table 3 Medians (inter-quartile ranges) of outcome measures, on enrolment (before PBM treatment) and after PBM treatment for both groups
On enrolment (n = 12) | After 12 weeks of clinic-treatment (n = 12) | After 25 or 40 weeks of home-treatment (n = 10) | |
|---|---|---|---|
Mobility tests | |||
10MWT walk speed (m/s) | 1.12 (0.29) | 1.70 (0.35)** | 1.74 (0.41) |
10MWT stride length (m) | 0.52 (0.06) | 0.67 (0.11)** | 0.75 (0.06) |
TUG (s) | 8.0 (1.6) | 7.1 (1.3)** | 6.58 (1.9)** |
TUG motor (s) | 8.6 (3.2) | 7.6 (2.0)** | 10.4 (2.5)* |
TUG cognitive (s) | 10.4 (2.5) | 6.9 (2.3)** | 9.5 (5.1)** |
Dynamic Balance test | |||
Step test - affected leg (n) | 12.0 (5.0) | 16.5 (4.5)** | 17.5 (5.3)** |
Step test - unaffected leg (n) | 12.0 (2.0) | 15.5 (4.8)** | 19.5 (6.3)** |
Cognition test | |||
MoCA | 26 (3.0) | 28 (2.0)** | 29.9 (1.0)** |
Fine Motor Skill tests | |||
NHPT - affected hand (s) | 22.8 (4.0) | 27.5 (7.5) | 23.9 (7.0) |
NHPT - unaffected hand (s) | 23.3 (6.0) | 24.0 (7.2) | 23.2 (6.2) |
Spiral test - dominant hand (s) | 30.9 (11.0) | 27.3 (10.6)** | 23.4 (9.3)* n = 11 |
Static Balance tests | |||
TS affected leg behind (s) | 2.0 (6.50) | 5.8 (17.00)* | 3.9 (26.6) n = 9 |
TS unaffected leg behind (s) | 1.5 (4.75) | 2.75 (19.08) | 3.9 (26.8) n = 9 |
SLS affected leg raised (s) | 2.0 (4.5) | 0.8 (3.3) | 4.5 (2.8) n = 6 |
SLS unaffected leg raised (s) | 1.5 (2.0) | 1.4 (3.4) | 24.5 (21.5) n = 6 |